Estrada, Sarah M.
Thagard, Andrew S.
Dehart, Mary J.
Damicis, Jennifer R.
Dornisch, Elisabeth M.
Ippolito, Danielle L.
Burd, Irina
Napolitano, Peter G.
Ieronimakis, Nicholas
Funding for this research was provided by:
United States Department of Defense | U.S. Air Force
United States Department of Defense | U.S. Army
Article History
Received: 13 September 2019
Revised: 6 December 2019
Accepted: 9 December 2019
First Online: 6 January 2020
Change Date: 30 June 2020
Change Type: Correction
Change Details: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Competing interests
: Authors S.M.E., A.S.T., P.G.N., and N.I. have filed a provisional patent related to the targeting of Nr4a1 for reducing neuroinflammation with preterm labor. The authors have not received any monetary benefits for this filing or have any conflicts of interest regarding this research study to declare. Funding agencies had no influence on the bearing of this study.
: Some authors are federal employees or members of the armed forces. The views expressed are those of the authors and do not reflect the official policy or position of the U.S. Army Medical Department, Department of the Army, Department of Defense or the U.S. Government. Animals involved in this study were maintained in accordance with the ‘Guide for the Care and Use of Laboratory Animals’ published by the National Research Council/Institute of Laboratory Animal Research (ILAR).